Jenny Y. Y. Ooi - Concepedia

Author

Jenny Y. Y. Ooi

Baker Heart and Diabetes Institute ORCID

Also Known As

J. Ooi, Jenny Ooi, Jenny Y Ooi, Jenny Y Y Ooi, Jenny Y. Y. Ooi, Jenny Y.Y. Ooi, Jenny YY Ooi, Jenny Yy Ooi, Jenny Y. Y. Ooi, Jer Ping Ooi

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Baker Heart and Diabetes Institute Monash University UNSW Sydney The University of Melbourne La Trobe University

About

Jenny Y. Y. Ooi is an author at Baker Heart and Diabetes Institute specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	744
2	Natural Sciences	3	3	277
3	Health Sciences	2	2	103
4	Public Health	2	2	177
5	Engineering	1	1	56

Jenny Y. Y. Ooi

Publications

979

Citations

H-Index

Page 1

	Year	Citations
HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes Jenny Y. Y. Ooi, Natasha Tuano, Haloom Rafehi, Epigenetics Cardiac MuscleHistone AcetylationGeneticsTarget GenesDirect Histone Targets	2015	139
The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice Geeta Sapra, Yow Keat Tham, Nelly Cemerlang, Nature Communications CardiomyopathyHeart FailureMolecular PhysiologyCardiovascular DiseaseMedicine	2014	104
Vascular histone deacetylation by pharmacological HDAC inhibition Haloom Rafehi, Aneta Balcerczyk, Sebastian Lunke, Genome Research Histone ModificationsHdac InhibitorsEpigenetic ChangeGeneticsPharmacotherapy	2014	90
Lipidomic Profiles of the Heart and Circulation in Response to Exercise versus Cardiac Pathology: A Resource of Potential Biomarkers and Drug Targets Yow Keat Tham, Bianca C. Bernardo, Kevin Huynh, Cell Reports Heart FailurePotential BiomarkersCardiovascular FunctionCardiovascular ToxicityMetabolic Syndrome	2018	76
Therapeutic silencing of miR‐652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy Bianca C. Bernardo, Sally Nguyen, Catherine E. Winbanks, The FASEB Journal Heart FailureCardiac RegenerationCardiovascular FunctionTherapeutic SilencingCardiology	2014	75
Silencing of miR-34a Attenuates Cardiac Dysfunction in a Setting of Moderate, but Not Severe, Hypertrophic Cardiomyopathy Bianca C. Bernardo, Xiao‐Ming Gao, Yow Keat Tham, PLoS ONE Heart FailureCardiac Progenitor CellsPathologyCardiac RegenerationCardiovascular Translational Research	2014	73
Dynamic changes in the cardiac methylome during postnatal development Choon Boon Sim, Mark Ziemann, Antony Kaspi, The FASEB Journal	2014	66
A brain-derived MeCP2 complex supports a role for MeCP2 in RNA processing Steven W. Long, Jenny Y. Y. Ooi, Peter M. Yau, Bioscience Reports	2010	60
Identification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseases Jenny Y. Y. Ooi, Bianca C. Bernardo, Saloni Singla, RNA Biology Heart FailureEngineeringImmunologyPathologyMir-34 Family	2016	56
Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure Overload Bianca C. Bernardo, Sally Nguyen, Xiao‐Ming Gao, Scientific Reports	2016	49

Page 1